Telomerase reverse transcriptase (TERT) promoter mutations have been detected in more than 50% of primary adult GBM and are correlated with increased telomerase activity [24,25], having been linked to lower survival times in GBM patients [26]. This evidence concerns the gene TERT and glioblastoma.